federal trade commission pharmacy benefit managers

Pharmacy benefit managers inflated drug prices by $7.3B

Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says

The largest pharmacy-benefit managers hiked the prices of certain drugs dispensed through their own pharmacies, according to a new report by the Federal Trade Commission released on Tuesday. The markups helped the PBMs reap $7.

ConsumerAffairs · 2d

Another FTC report is highly critical of pharmacy benefit managers

In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in many prescription drug transa

Honolulu Star-Advertiser · 2d

FTC: Pharmacy benefit managers inflated drug prices by $7.3B

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies,

policymed.com2d

Second Federal Trade Commission Report on Pharmacy Benefit Managers (PBM’s) Focuses on Specialty Generics

The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center ...

The Hill3d

PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Pharmacy benefit managers inflated drug prices by $7.3B

Trending now